1. Real-life clinical data of cabozantinib for unresectable hepatocellular carcinoma: efficacy, safety and prognostic factors. (March 2021) Authors: Tovoli, F.; Dadduzio, V.; De Lorenzo, S.; Rimassa, L.; Masi, G.; Iavarone, M.; Marra, F.; Garajova, I.; Brizzi, M.P.; Daniele, B.; Trevisani, F.; Messina, C.; Clemente, F. Di; Pini, S.; Cabibbo, G.; Granito, A.; Rizzato, M.D.; Zagonel, V.; Brandi, G.; Pressiani, T. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗